No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Amazon To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Wednesday
BofA Securities Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Cuts Target Price to $46
Express News | 4D Molecular Therapeutics Inc : BofA Global Research Cuts Price Objective to $46 From $79
Express News | 4Dmt Announces Landmark Publication of 4D-150 Preclinical Data for the Treatment of Neovascular Retinopathies in Iovs
We Think 4D Molecular Therapeutics (NASDAQ:FDMT) Can Afford To Drive Business Growth
4D Molecular Therapeutics, Inc. (FDMT): An Oversold Healthcare Stock to Invest In Now